Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 4 · 57.1%GRADE not reported 0 · 0%Very low 3 · 42.9%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Immediate‐release methylphenidate vs lithium

Clinical impression: severity ‐ not reported · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

The review found no eligible studies for this question.

1 finding from 1 review

Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Immediate‐release methylphenidate vs lithium

Clinical impression: improvement‐ not reported · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

The review found no eligible studies for this question.

1 finding from 1 review

Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Immediate‐release methylphenidate vs lithium

Anxiety · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

1 finding from 1 review

Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Very low

Immediate‐release methylphenidate vs lithium

Depression: investigator‐rated · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

1 finding from 1 review

Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Very low

Immediate‐release methylphenidate vs lithium

Harms: adverse events (poorly assessed and reported) · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

The review found no eligible studies for this question.

1 finding from 1 review

Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Immediate‐release methylphenidate vs lithium

ADHD symptoms · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

1 finding from 1 review

Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Very low

Immediate‐release methylphenidate vs lithium

Efficacy (changes in symptoms of ADHD): participant‐rated ‐ not reported · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

The review found no eligible studies for this question.

1 finding from 1 review

Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found